SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031359
Filing Date
2022-11-10
Accepted
2022-11-10 16:16:54
Documents
88
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1415053
2 ex10-2.htm EX-10.2 103459
3 ex10-3.htm EX-10.3 100893
4 ex10-4.htm EX-10.4 101000
5 ex10-5.htm EX-10.5 17094
6 ex31-1.htm EX-31.1 10830
7 ex32-1.htm EX-32.1 4603
  Complete submission text file 0001493152-22-031359.txt   8898342

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE lctx-20220930.xsd EX-101.SCH 69518
9 XBRL CALCULATION FILE lctx-20220930_cal.xml EX-101.CAL 74384
10 XBRL DEFINITION FILE lctx-20220930_def.xml EX-101.DEF 283422
11 XBRL LABEL FILE lctx-20220930_lab.xml EX-101.LAB 513472
12 XBRL PRESENTATION FILE lctx-20220930_pre.xml EX-101.PRE 400969
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1720164
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 221377455
SIC: 2836 Biological Products, (No Diagnostic Substances)